Chromosome 5q deletion syndrome

Source: Wikipedia, the free encyclopedia.
Chromosome 5q deletion syndrome
Other namesChromosome 5q monosomy, 5q- syndrome
Photomicrograph of bone marrow showing abnormal mononuclear megakaryocytes typical of 5q- syndrome
SpecialtyHematology Edit this on Wikidata

Chromosome 5q deletion syndrome is an acquired, hematological disorder characterized by loss of part of the long arm (

q arm, band 5q33.1) of human chromosome 5 in bone marrow myelocyte cells. This chromosome abnormality is most commonly associated with the myelodysplastic syndrome
.

It should not be confused with "partial trisomy 5q", though both conditions have been observed in the same family.[1] This should not be confused with the

cri du chat (5p deletion) syndrome which is a deletion of the short arm of the 5th chromosome.[citation needed
] Diagnosis is achieved through marrow biopsy.

Presentation

The 5q-syndrome is characterized by

thrombocytosis, erythroblastopenia, megakaryocyte hyperplasia with nuclear hypolobation, and an isolated interstitial deletion of chromosome 5. The 5q- syndrome is found predominantly in females of advanced age.[2]

Causes

Several

Histology

This syndrome affects

megakaryocytes. They are more numerous than usual, small and mononuclear. There may be accompanying erythroid hypoplasia in the bone marrow.[6]

Treatment

FDA approved for red blood cell (RBC) transfusion-dependent anemia due to low or intermediate-1 (int-1) risk myelodysplastic syndrome (MDS) associated with chromosome 5q deletion with or without additional cytogenetic abnormalities.[8] There are several possible mechanisms that link the haploinsufficiency molecular lesions with lenalidomide sensitivity.[4][9]

Prognosis

Most affected people have a stable clinical course but are often transfusion dependent.[citation needed]

References

External links